Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 46Triple Negative Breast Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 3Recurrence 2Unilateral Breast Neoplasms 1Pain 1Neoplasms 1Lymphedema 1Li-Fraumeni Syndrome 1Inflammation 1Hamartoma Syndrome, Multiple 1Cystic Fibrosis 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1Breast Cancer Invasive 1Breast Cancer Female 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Mastectomy × Clear all
NCT05663801 2024-12-27

Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy

Beni-Suef University

Phase 2 Completed
72 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡